BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis

NASDAQ:BTSG • US10950A1060

41.43 USD
+1.3 (+3.24%)
At close: Feb 27, 2026
41.43 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, BTSG scores 3 out of 10 in our fundamental rating. BTSG was compared to 101 industry peers in the Health Care Providers & Services industry. The financial health of BTSG is average, but there are quite some concerns on its profitability. BTSG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BTSG was profitable.
  • In the past year BTSG had a positive cash flow from operations.
  • In the past 5 years BTSG reported 4 times negative net income.
  • In multiple years BTSG reported negative operating cash flow during the last 5 years.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of BTSG (2.14%) is comparable to the rest of the industry.
  • The Return On Equity of BTSG (7.13%) is better than 64.36% of its industry peers.
  • BTSG has a Return On Invested Capital of 4.68%. This is comparable to the rest of the industry: BTSG outperforms 52.48% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BTSG is significantly below the industry average of 9.08%.
  • The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROIC 4.68%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • BTSG has a Profit Margin (1.04%) which is in line with its industry peers.
  • BTSG has a Operating Margin (2.15%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of BTSG has grown nicely.
  • The Gross Margin of BTSG (12.30%) is worse than 69.31% of its industry peers.
  • BTSG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

  • BTSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BTSG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 3.48 indicates that BTSG is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.48, BTSG is doing good in the industry, outperforming 71.29% of the companies in the same industry.
  • BTSG has a debt to FCF ratio of 9.17. This is a negative value and a sign of low solvency as BTSG would need 9.17 years to pay back of all of its debts.
  • BTSG has a Debt to FCF ratio (9.17) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.36 is on the high side and indicates that BTSG has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.36, BTSG is not doing good in the industry: 66.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Altman-Z 3.48
ROIC/WACC0.56
WACC8.3%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • BTSG has a Current Ratio of 1.79. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
  • BTSG has a Current ratio of 1.79. This is in the better half of the industry: BTSG outperforms 73.27% of its industry peers.
  • A Quick Ratio of 1.38 indicates that BTSG should not have too much problems paying its short term obligations.
  • BTSG's Quick ratio of 1.38 is in line compared to the rest of the industry. BTSG outperforms 57.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.38
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 105.45% over the past year.
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.31%

3.2 Future

  • Based on estimates for the next years, BTSG will show a very strong growth in Earnings Per Share. The EPS will grow by 33.51% on average per year.
  • BTSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.34% yearly.
EPS Next Y21.25%
EPS Next 2Y22.21%
EPS Next 3Y31.51%
EPS Next 5Y33.51%
Revenue Next Year14.82%
Revenue Next 2Y14.07%
Revenue Next 3Y15.73%
Revenue Next 5Y18.34%

3.3 Evolution

BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 36.66, which means the current valuation is very expensive for BTSG.
  • BTSG's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, BTSG is valued a bit more expensive.
  • A Price/Forward Earnings ratio of 30.24 indicates a quite expensive valuation of BTSG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BTSG is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of BTSG to the average of the S&P500 Index (28.05), we can say BTSG is valued inline with the index average.
Industry RankSector Rank
PE 36.66
Fwd PE 30.24
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BTSG's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BTSG is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.06
EV/EBITDA 22.12
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BTSG's earnings are expected to grow with 31.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.73
PEG (5Y)N/A
EPS Next 2Y22.21%
EPS Next 3Y31.51%

0

5. Dividend

5.1 Amount

  • No dividends for BTSG!.
Industry RankSector Rank
Dividend Yield 0%

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (2/27/2026, 8:00:02 PM)

After market: 41.43 0 (0%)

41.43

+1.3 (+3.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27
Earnings (Next)04-30
Inst Owners73.18%
Inst Owner Change-7.01%
Ins Owners2.49%
Ins Owner Change-8.66%
Market Cap7.47B
Revenue(TTM)N/A
Net Income(TTM)129.59M
Analysts86.36
Price Target45.36 (9.49%)
Short Float %7.33%
Short Ratio4.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.58%
PT rev (3m)12.81%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)0.52%
EPS NY rev (1m)0%
EPS NY rev (3m)6.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 36.66
Fwd PE 30.24
P/S 0.6
P/FCF 27.06
P/OCF 21.4
P/B 4.11
P/tB N/A
EV/EBITDA 22.12
EPS(TTM)1.13
EY2.73%
EPS(NY)1.37
Fwd EY3.31%
FCF(TTM)1.53
FCFY3.7%
OCF(TTM)1.94
OCFY4.67%
SpS68.83
BVpS10.08
TBVpS-5.95
PEG (NY)1.73
PEG (5Y)N/A
Graham Number16.01
Profitability
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROCE 5.92%
ROIC 4.68%
ROICexc 4.83%
ROICexgc 14.34%
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
FCFM 2.22%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Debt/EBITDA 5.55
Cap/Depr 40.71%
Cap/Sales 0.59%
Interest Coverage 1.44
Cash Conversion 78.31%
Profit Quality 213.06%
Current Ratio 1.79
Quick Ratio 1.38
Altman-Z 3.48
F-Score7
WACC8.3%
ROIC/WACC0.56
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y21.25%
EPS Next 2Y22.21%
EPS Next 3Y31.51%
EPS Next 5Y33.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.31%
Revenue Next Year14.82%
Revenue Next 2Y14.07%
Revenue Next 3Y15.73%
Revenue Next 5Y18.34%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year63.51%
EBIT Next 3Y29.01%
EBIT Next 5Y26.38%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%

BRIGHTSPRING HEALTH SERVICES / BTSG FAQ

Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?

ChartMill assigns a fundamental rating of 4 / 10 to BTSG.


Can you provide the valuation status for BRIGHTSPRING HEALTH SERVICES?

ChartMill assigns a valuation rating of 4 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Fairly Valued.


How profitable is BRIGHTSPRING HEALTH SERVICES (BTSG) stock?

BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.


What is the financial health of BRIGHTSPRING HEALTH SERVICES (BTSG) stock?

The financial health rating of BRIGHTSPRING HEALTH SERVICES (BTSG) is 4 / 10.


What is the earnings growth outlook for BRIGHTSPRING HEALTH SERVICES?

The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 21.25% in the next year.